SecBot SecBot

CDNA

CareDx, Inc.
Nasdaq· Services-Medical Laboratories· Inc. DE· CIK 0001217234 Healthcare & Medical Devices
$73.72 −4.16 (−5.34%)
Nov 16 4:00 PM ET · prev $77.88
Market cap
$4.2B
Mid cap
Consensus
Buy
77% Buy or better · 13 analysts
Median target
$92.00
+25% · range $90.00–100.00
1 year
+375.3%
from $15.51 · Nov 17
30 days
+9.9%
from $67.08
52-week range
$15.51–88.47
−17% from high · low Nov 17
Avg volume 20D
1.34M
Oct 30 spike 3.55M
Short interest
7.19M
≈13.7% of shares · +7.0%
Days to cover
5.3
at average volume
Insider net
−$16.4M
0 buyers · 7 sellers · since Jun 12
New fund stakes
2
Q3 2026 13F · 1 exit
Reddit crowd
50°
Neutral · 1 mention this week
SecBot read MIXED 7 reports · 90 days
Balance 1 bearish · 1 bullish · 5 neutral oldest → newest, height = score
Avg score ·High conf. 5/7

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    7 insiders sold $16.4M.

  • InstitutionsMIXED

    Q3 2026: 35 added (2 new), 26 trimmed or exited. Largest new: Empowered Funds $15.4M.

  • AnalystsBULLISH

    10 of 13 rate it Buy or better. Every target is above the price.

  • Short sellersSTEADY

    Short interest +7.0% to 7.19M shares. 5.3 days to cover, ≈13.7% of shares.

  • TrendUPTREND

    10% above its 50-day average.

  • SocialQUIET

    Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup is alerting.

Who's buying

13F· Q3 2026
2
new positions
1
exit
$15.4M
in new stakes · top 1 shown
FundMoveSharesValue
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPDOUBLED2,059,397$133.9M
FRANKLIN TEMPLETON INCDOUBLED985,690$84.6M
Qube Research & Technologies LtdADD656,872$42.7M
Sumitomo Mitsui Trust Group, Inc.TRIM627,020$40.8M
Nuveen, LLCDOUBLED517,024$33.6M
MORGAN STANLEYTRIM444,522$28.9M
Boston PartnersNEAR_EXIT381,355$24.8M
Russell Investments Group, Ltd.TRIM289,524$18.8M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

13 analysts
Buy 77% rate it Buy or better
Strong Buy5Buy5Hold3Sell0Strong Sell0
12-month targets · 7 analysts

Price is below the lowest target. Median implies +25%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 11, 2026Piper Sandler
INITIATE
INITIATEOverweight
Oct 30, 2026BTIG
MAINTAIN
MAINTAINBuy
Oct 27, 2026BTIG
MAINTAIN
MAINTAINBuy
Oct 19, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
Sep 24, 2026BTIG
MAINTAIN
MAINTAINBuy
Sep 2, 2026Canaccord Genuity
INITIATE
INITIATEBuy

Washington

Corporate Lobbying

26 lobbying filings and 3 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$0
bought · 0 insiders
$16.4M
sold · 7 insiders
DateInsiderTypeValue
Nov 10, 2026
Bickerstaff George
Director
Nov 10, 2026
EXERCISE$221.1K
Nov 10, 2026
Novack Jeffrey Adam
Secretary and General Counsel
Nov 10, 2026
SELL$75.0K
Nov 10, 2026
Novack Jeffrey Adam
Secretary and General Counsel
Nov 10, 2026
SELL$241.1K
Nov 10, 2026
Novack Jeffrey Adam
Secretary and General Counsel
Nov 10, 2026
SELL$16.2K
Nov 6, 2026
Novack Jeffrey Adam
Secretary and General Counsel
Nov 6, 2026
TAX W/H$118.2K
Nov 5, 2026
Kennedy Keith
CFO & COO
Nov 5, 2026
EXERCISE$1.5M
Nov 5, 2026
Kennedy Keith
CFO & COO
Nov 5, 2026
SELL$2.2M
Nov 5, 2026
Kennedy Keith
CFO & COO
Nov 5, 2026
SELL$958.4K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Reddit
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 1 0 in posts · 1 in comments
Recent comments
All social signals and their track records

Short side

FINRA· Oct 30, 2026
7,187,391
shares short
+7.0%
vs prior settlement
5.3
days to cover
≈13.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 Lobbying
🔒 Fresh data, subscribers only
Nov 12, 2026 SEC
Two CareDx insiders, including the CFO/COO and General Counsel, sold a combined $2.40M in open-market sales over a…
CLUSTER · Impact 2/10
Nov 12, 2026 SEC
Michael Goldberg, a director of CareDx, filed a Form 144 notice of intent to sell 13,800 shares of common stock, with…
144 · Impact 2/10
Nov 10, 2026 SEC
Jeffrey Novack, an officer of CareDx, filed a Form 144 notice of intent to sell 4,096 shares of common stock, with an…
144 · Impact 2/10
Nov 10, 2026 Insider
Bickerstaff George acquired via exercise 15,000 shares
Director @ $14.74 ($221.1K)
Nov 10, 2026 Insider
Novack Jeffrey Adam sold 900 shares
Secretary and General Counsel @ $83.33 ($75.0K)
Nov 10, 2026 Insider
Novack Jeffrey Adam sold 2,996 shares
Secretary and General Counsel @ $80.47 ($241.1K)
Sep 30, 2026 Inst.
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP · DOUBLED
2,059,397 shares ($133.9M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

16 filings · 4 bullish · 1 bearish · 11 neutral
All CDNA filing & press-release reports (16)